CI-1 Spiriva® RESPIMAT® (tiotropium bromide) Inhalation Spray United States Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee

First Page		Document Content
Clinical research Pharmacology Design of experiments Evaluation methods Bioethics Tiotropium bromide Placebo-controlled study Dose-ranging study Clinical trial Medicine Science Research		CI-1 Spiriva® RESPIMAT® (tiotropium bromide) Inhalation Spray United States Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,70 MB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document